Targeting hypoxia in solid and haematological malignancies
Abstract Tumour hypoxia is a known and extensively researched phenomenon that occurs in both solid and haematological malignancies. As cancer cells proliferate, demand for oxygen can outstrip supply reducing tumour oxygenation. In solid tumours this is contributed to by disorganized blood vessel dev...
Main Authors: | Bill Harris, Sana Saleem, Natalie Cook, Emma Searle |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13046-022-02522-y |
Similar Items
-
Risk factors for haemorrhage in patients with haematological malignancies
by: Estcourt, LJ
Published: (2014) -
WT1 AND MULTIPLE MYELOMA: A POTENTIAL IMMUNOTHERAPEUTIC APPROACH FOR HAEMATOLOGICAL MALIGNANCIES
by: Ilaria Dulcamare
Published: (2022-12-01) -
Lower versus higher oxygenation targets in ICU patients with haematological malignancy — insights from the HOT-ICU trial
by: Thomas L. Klitgaard, et al.
Published: (2022-12-01) -
Immunotherapy and immunomodulation for haematological malignancies
by: Mussai, F, et al.
Published: (2012) -
Opportunistic infections in patients with haematological malignancies in Nigeria
by: Bassey Ewa Ekeng, et al.
Published: (2022-01-01)